PROGRAF AND KIDNEY TRANSPLANTS 
Transplantation is an amazing procedure. But our bodies are not used to foreign organs. View animation. That is why anti-rejection medications like Prograf are so important for the survival of your new kidney. Prograf helps your body to accept your new kidney. There is also a low potential for the development of side effects like high cholesterol, unwanted hair growth, and dental problems such as gum overgrowth. Kidney recipients taking Prograf have few episodes of acute rejection. Patients on Prograf have good five year survival rates. That is why taking your medications is so important. But Prograf may not be right for everyone. Only your doctor can decide if Prograf is right for you. Prograf® (tacrolimus capsules and injection) is approved for the prevention of rejection in patients who have received a liver or kidney transplant. Only physicians and facilities specializing in transplantation should manage patients taking Prograf. Anti-rejection medications may result in an increased possibility of developing an infection or lymphoma, a type of cancer. In clinical studies, up to 20% of patients taking Prograf developed insulin dependent diabetes after transplant, but in some patients, after two years, insulin was no longer required. Black and Hispanic kidney transplant patients were at an increased risk. Prograf has been associated with toxicity to the kidneys and nervous system. Common side effects are tremor, headache, high blood pressure, diarrhea, nausea and changes in kidney function. Prograf should not be used in patients allergic to tacrolimus. Prograf injection should not be used in patients allergic to castor oil. Next | Health Center |
|
